Alnara Pharmaceuticals develops and commercializes orally-delivered protein therapeutics for the treatment of metabolic diseases.
Business Model:
Revenue: $10M
Employees: 2-10
Address:
City: Cambridge
State: Massachusetts
Zip:
Country: United States
Alnara Pharmaceuticals, Inc. is dedicated to developing novel protein therapeutics for the treatment of metabolic diseases. The company&s;s innovative approach focuses on designing effective protein therapies that can be orally delivered directly to the gastrointestinal tract without being absorbed into the bloodstream.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2010 | Series B | 1 | $35M |
MPM Capital MPM Capital MPM Capital MPM Capital |
10/2008 | Series A | 4 | $20M |
Third Rock Ventures Frazier Healthcare Partners Longwood Fund Bessemer Venture Partners Frazier Healthcare Partners Third Rock Ventures Third Rock Ventures Frazier Healthcare Partners Longwood Fund Bessemer Venture Partners Frazier Healthcare Partners Third Rock Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|